Rapid and Efficient Combined Decellularization with Physical, Chemical and Enzymatic Treatment for Production of Bovine-Derived Meniscal Implant to Replace Damaged Meniscus.
Young-Bock Shim, Sang Hoon Lee, YoungWoo Ryu, Sang Hyun Jung, Shin Young Park, Yu Jin Lee, Hong Hee Jung, Dae Hyeok Yang, Heung Jae Chun
{"title":"Rapid and Efficient Combined Decellularization with Physical, Chemical and Enzymatic Treatment for Production of Bovine-Derived Meniscal Implant to Replace Damaged Meniscus.","authors":"Young-Bock Shim, Sang Hoon Lee, YoungWoo Ryu, Sang Hyun Jung, Shin Young Park, Yu Jin Lee, Hong Hee Jung, Dae Hyeok Yang, Heung Jae Chun","doi":"10.1007/s13770-026-00796-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Xenogeneic menisci offer a promising biomaterial with high biocompatibility, closely resembling the native meniscus. However, to enable clinical application in humans, decellularization is essential to remove cellular components that may trigger graft rejection.</p><p><strong>Method: </strong>We developed a combined decellularization protocol for bovine-derived meniscus tissue, integrating physical stimulation (sonication and vacuum), chemical treatments (hypotonic and hypertonic solutions, and sodium dodecyl sulfate [SDS]), and enzymatic digestion (trypsin and nucleases). The decellularization efficiency was confirmed not only by DNA reduction rate, but also by residual DNA, DNA fragmentation and histology. Subsequently, cytotoxicity, biocompatibility, and mechanical properties were assessed.</p><p><strong>Results: </strong>This combined decellularization achieved a DNA removal efficiency of up to 94.94%, enabled rapid decellularization within 5 days, and preserved collagen content, resulting in a high-quality xeno meniscal implant (XMI).</p><p><strong>Conclusion: </strong>The XMI produced through this combined decellularization process demonstrates strong potential as a scaffold for the treatment of meniscal injuries.</p>","PeriodicalId":23126,"journal":{"name":"Tissue engineering and regenerative medicine","volume":" ","pages":"537-550"},"PeriodicalIF":5.1000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13212883/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering and regenerative medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s13770-026-00796-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Xenogeneic menisci offer a promising biomaterial with high biocompatibility, closely resembling the native meniscus. However, to enable clinical application in humans, decellularization is essential to remove cellular components that may trigger graft rejection.
Method: We developed a combined decellularization protocol for bovine-derived meniscus tissue, integrating physical stimulation (sonication and vacuum), chemical treatments (hypotonic and hypertonic solutions, and sodium dodecyl sulfate [SDS]), and enzymatic digestion (trypsin and nucleases). The decellularization efficiency was confirmed not only by DNA reduction rate, but also by residual DNA, DNA fragmentation and histology. Subsequently, cytotoxicity, biocompatibility, and mechanical properties were assessed.
Results: This combined decellularization achieved a DNA removal efficiency of up to 94.94%, enabled rapid decellularization within 5 days, and preserved collagen content, resulting in a high-quality xeno meniscal implant (XMI).
Conclusion: The XMI produced through this combined decellularization process demonstrates strong potential as a scaffold for the treatment of meniscal injuries.
期刊介绍:
Tissue Engineering and Regenerative Medicine (Tissue Eng Regen Med, TERM), the official journal of the Korean Tissue Engineering and Regenerative Medicine Society, is a publication dedicated to providing research- based solutions to issues related to human diseases. This journal publishes articles that report substantial information and original findings on tissue engineering, medical biomaterials, cells therapy, stem cell biology and regenerative medicine.